Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia

ClinicalTrials.gov ID: NCT02595528

Public ClinicalTrials.gov record NCT02595528. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 20, 2026, 7:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Double-masked, Randomized, Vehicle-Controlled, Study of the Concurrent Use of AGN-190584 and AGN-199201 in Patients With Presbyopia

Study identification

NCT ID
NCT02595528
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Allergan
Industry
Enrollment
163 participants

Conditions and interventions

Conditions

Interventions

  • AGN-199201 ophthalmic solution Drug
  • AGN-190584 ophthalmic solution Drug
  • AGN-190584 vehicle Drug
  • AGN-199201 + AGN-190584 Combination Drug
  • AGN-199201 vehicle Drug

Drug

Eligibility (public fields only)

Age range
40 Years to 50 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 28, 2016
Primary completion
Oct 17, 2017
Completion
Oct 17, 2017
Last update posted
Dec 21, 2020

2016 – 2017

United States locations

U.S. sites
20
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Sall Research Medical Center Artesia California 90701
Milton M. Hom, OD, FAAO Azusa California 91702
WCCT Global, LLC Costa Mesa California 92626
The Eye Research Foundation Newport Beach California 92663
North Bay Eye Associates, Inc. Petaluma California 94954
Martel Eye Medical Group Rancho Cordova California 95670
West Coast Eye Care San Diego California 92115
Corneal Consultants of Colorado, P.C. Littleton Colorado 80120
Mid Florida Eye Center Mt. Dora Florida 32757
Clayton Eye Center Morrow Georgia 30260
Price Vision Group Indianapolis Indiana 46260
Specialized Eye Care Baltimore Maryland 21210
Comprehensive Eye Care, Ltd Washington Missouri 63090
Cleveland Eye Clinic Brecksville Ohio 44141
Scott & Christie and Associates, PC Cranberry Township Pennsylvania 16066
Total Eye Care, PA Memphis Tennessee 38119
Cataract and Glaucoma Center El Paso Texas 79902
Medical Center Ophthalmology Associates San Antonio Texas 78240
Hoopes Durrie Rivera Research, LLC Draper Utah 84020
The Eye Centers of Racine & Kenosha Kenosha Wisconsin 53142

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02595528, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 21, 2020 · Synced Jul 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02595528 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →